Skip to main content

Table 1 Patient characteristics

From: A novel predictive factor for the onset time of docetaxel-induced onychopathy: a multicenter retrospective study

Characteristics

Value (n = 95)

Age (mean years ± S.D.)

62.1 ± 12.0

Gender (n, male/female)

54/41

Body surface area (m2, mean ± S.D.)

1.57 ± 0.17

Concomitant use of 5-FU drugsa) (n, Y/N)

33/62

Hemoglobin at the start of administration (mean g/dL ± S.D.)

11.2 ± 1.8

Primary site

Stomach, n (%)

32

(33.7)

Breast, n (%)

23

(24.2)

Lung, n (%)

19

(20.0)

Prostatic, n (%)

9

(9.5)

Others, n (%)

12

(12.6)

  1. a)5-FU drugs: 5-fluorouracil, capecitabine, tegafur/gimeracil/oteracil